In American men, prostate cancer is the most common cancer and the second leading cause of cancer death. Confirmed risk factors for prostate cancer include increased age, African-American ethnicity, and having first-degree relatives with the disease; high fat consumption may also be implicated. Appropriate screening begins with digital rectal examination and measurement of prostate-specific antigen; biopsy is required to confirm the diagnosis. Watchful waiting, surgery, and radiation are standard treatment options. Adverse effects of the more aggressive therapies include urinary incontinence and erectile dysfunction
PURPOSE: Guidelines for screening men at high risk for prostate cancer remain under investigation. W...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...
ImportanceIn the United States, the lifetime risk of being diagnosed with prostate cancer is approxi...
Prostate cancer is the most common non-skin cancer in the United States, and the second leading caus...
bout 218,890 new prostate cancer diagnoses were expected in the United States during 2007, with 27,0...
Prostate cancer is the second most common cancer among men after skin cancer; as well as being the t...
BackgroundThe advent of prostate specific antigen (PSA) testing in the United States of America (USA...
Prostate cancer is more common in the western countries, least common in Asia, and the leading cause...
Prostate adenocarcinoma is the most common cancer affecting men in the United States. Existing facto...
In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to upda...
Introduction and Aim: Prostate cancer (Pc) is a major public health problem, affecting 679,000 men a...
Prostate cancer is the most commonly diagnosed non-cutaneous cancer and the third most common cause ...
Screening for prostate cancer is technically feasible. Recent advances in diagnostic strategies have...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
PURPOSE: Guidelines for screening men at high risk for prostate cancer remain under investigation. W...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...
ImportanceIn the United States, the lifetime risk of being diagnosed with prostate cancer is approxi...
Prostate cancer is the most common non-skin cancer in the United States, and the second leading caus...
bout 218,890 new prostate cancer diagnoses were expected in the United States during 2007, with 27,0...
Prostate cancer is the second most common cancer among men after skin cancer; as well as being the t...
BackgroundThe advent of prostate specific antigen (PSA) testing in the United States of America (USA...
Prostate cancer is more common in the western countries, least common in Asia, and the leading cause...
Prostate adenocarcinoma is the most common cancer affecting men in the United States. Existing facto...
In 2009, the American Cancer Society (ACS) initiated a series of systematic evidence reviews to upda...
Introduction and Aim: Prostate cancer (Pc) is a major public health problem, affecting 679,000 men a...
Prostate cancer is the most commonly diagnosed non-cutaneous cancer and the third most common cause ...
Screening for prostate cancer is technically feasible. Recent advances in diagnostic strategies have...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
PURPOSE: Guidelines for screening men at high risk for prostate cancer remain under investigation. W...
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a...
Since widespread prostate cancer screening was introduced in the United States in the late 1980s and...